www.mediafax.ro/sanatate/descoperire-medicala-pent

An experimental therapy using CAR-T cells shows promise for patients with Stiff Person Syndrome, including improvements in mobility and daily activities. A study involving 26 adults demonstrated significant benefits after a single treatment dose. The therapy aims to rebalance the immune system by targeting B cells involved in the autoimmune response. While results are encouraging, further monitoring is needed to assess long-term effects and safety. Researchers believe this approach could lead to new treatments for other autoimmune neurological disorders.